ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SUMM Summit Therapeutics Plc

20.50
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Summit Therapeutics Plc LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.50 18.00 23.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summit Therapeutics plc Summit Therapeutics Plc : Holding(s) In Company

02/07/2018 5:47pm

UK Regulatory


 
TIDMSUMM 
 
 
   TR-1: Standard form for notification of major holdings 
 
 
 
 
1a. Identity of the issuer or the underlying issuer 
 of existing shares to which voting rights are attached(ii) 
 :                                                                                                                                   SUMMIT THERAPEUTICS PLC 
1b. Please indicate if the issuer is a non-UK issuer 
 (please mark with an "X" if appropriate) 
Non-UK issuer 
2. Reason for the notification (please mark the appropriate 
 box or boxes with an "X") 
An acquisition or disposal of voting rights                                                                                                                                       X 
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rights                                                                                                                                  X 
Other (please specify)(iii) : 
3. Details of person subject to the notification obligation(iv) 
Name                                                                                                     CANACCORD GENUITY GROUP INC 
City and country of registered office (if applicable)                                                    VANCOUVER, CANADA 
4. Full name of shareholder(s) (if different from 
 3.)(v) 
Name                                                                                                     DISCRETIONARY CLIENTS 
City and country of registered office (if applicable)                                                    As above 
5. Date on which the threshold was crossed or reached(vi) 
 :                                                                                                       29 MARCH 2018 
6. Date on which issuer notified (DD/MM/YYYY):                                                           02 JULY 2018 
7. Total positions of person(s) subject to the notification 
 obligation 
                                                                                                                                                                             Total number 
                                                                                                                                                                             of voting 
                                                     % of voting rights attached to shares (total of 8.  % of voting rights through financial instruments  Total of both in  rights of 
                                                                             A)                                      (total of 8.B 1 + 8.B 2)               % (8.A + 8.B)    issuer(vii) 
Resulting situation on the date on which threshold 
 was crossed or reached                                                                          6.7647                                                              6.7647    81,901,173 
Position of previous notification (if 
 applicable)                                                                                     4.1548                                                              4.1548 
 
 
 
 
 
 
 8. Notified details of the resulting situation on 
 the date on which the threshold was crossed or reached(viii) 
A: Voting rights attached to shares 
Class/type of 
 shares 
 ISIN code (if possible)   Number of voting rights(ix)                                                                 % of voting rights 
                                             Direct                                       Indirect                                       Direct                                      Indirect 
                            (Art 9 of Directive 2004/109/EC) (DTR5.1)    (Art 10 of Directive 2004/109/EC) (DTR5.2.1)   (Art 9 of Directive 2004/109/EC) (DTR5.1)   (Art 10 of Directive 2004/109/EC) (DTR5.2.1) 
GB00BN40HZ01               N/A                                                                              5,540,382                                         N/A                                         6.7647 
 
 
 
 
 
 
 
 
SUBTOTAL 8. 
 A                         5,540,382                                          6.7647 
 
B 1: Financial Instruments according to Art. 13(1)(a) 
 of Directive 2004/109/EC (DTR5.3.1.1 (a)) 
Type of       Expiration  Exercise/                Number of voting rights that may be acquired if the    % of 
 financial     date(x)     Conversion Period(xi)    instrument is                                         voting 
 instrument                                         exercised/converted.                                  rights 
 
 
 
                          SUBTOTAL 8. B 1 
 
B 2: Financial Instruments with similar economic effect 
 according to Art. 13(1)(b) of Directive 2004/109/EC 
 (DTR5.3.1.1 (b)) 
Type of      Expiration   Exercise/                Physical or cash    Number of voting rights            % of 
 financial    date(x)      Conversion Period (xi)  settlement(xii)                                        voting 
 instrument                                                                                               rights 
 
 
 
                                                   SUBTOTAL 8.B.2 
 
 
 
 
 
 
9. Information in relation to the person subject to 
 the notification obligation (please mark the 
 applicable box with an "X") 
Person subject to the notification obligation is not 
 controlled by any natural person or legal entity and 
 does not control any other undertaking(s) holding 
 directly or indirectly an interest in the (underlying) 
 issuer(xiii) 
Full chain of controlled undertakings through which 
 the voting rights and/or the 
 financial instruments are effectively held starting 
 with the ultimate controlling natural person or legal 
 entity(xiv) (please add additional rows as necessary)                                                                                             X 
            % of voting rights if it equals or is higher than   % of voting rights through financial instruments if   Total of both if it equals or is higher than the notifiable 
 Name(xv)                the notifiable threshold               it equals or is higher than the notifiable threshold                           threshold 
Canaccord 
 Genuity 
 Group 
 Inc.                                                  6.7647                                                                                                              6.7647 
Canaccord 
 Genuity 
 Wealth 
 Group 
 Holdings 
 Limited                                               6.7647                                                                                                              6.7647 
Canaccord 
 Genuity 
 Wealth 
 Group 
 Holdings 
 (Jersey) 
 Limited                                               6.7647                                                                                                              6.7647 
Hargreave 
 Hale Ltd                                              6.7647                                                                                                              6.7647 
 
10. In case of proxy voting, please identify: 
Name of the proxy holder 
The number and % of voting rights held 
The date until which the voting rights will be held 
 
11. Additional information(xvi) 
The change in the percentage of shares held is due 
 entirely to participation in the placing by Summit 
 Therapeutics plc, the shares from which were admitted 
 to AIM on 29/03/2018. 
 
 
 
 
Place of completion  BLACKPOOL, ENGLAND 
Date of completion   02 JULY 2018 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Summit Therapeutics plc via Globenewswire 
 
 
  http://www.summitplc.com/ 
 

(END) Dow Jones Newswires

July 02, 2018 12:47 ET (16:47 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Summit Therapeutics Chart

1 Year Summit Therapeutics Chart

1 Month Summit Therapeutics Chart

1 Month Summit Therapeutics Chart

Your Recent History

Delayed Upgrade Clock